Results 121 to 130 of about 50,619 (166)
Some of the next articles are maybe not open access.

Neuromuscular Blocking Agents in ARDS

New England Journal of Medicine, 2010
In this issue of the Journal, Papazian and colleagues1 present intriguing results of their study examining neuromuscular blockade in patients with severe, early acute respiratory distress syndrome (ARDS). The investigators randomly assigned 340 patients to receive the neuromuscular blocking agent cisatracurium or placebo for a period of 48 hours.
openaire   +2 more sources

Neuromuscular Blocking Agents

2010
Neuromuscular blocking agents have, perhaps, the most fascinating history among the drugs used in anesthesiology and intensive care. For centuries, South American aborigines had used curare to hunt animals before Claude Bernard showed in 1850 that these drugs act peripherally, blocking conduction where motor nerves meet the muscle.1 These historical ...
Gerardo Rodríguez   +2 more
openaire   +1 more source

Viral agents in neuromuscular pathology

In recent years, viral infections have been increasingly identified as major players in neuromuscular pathologies. This chapter presents an overview of the evidence and future directions for virus-induced neuromuscular disorders. Information is integrated on the global burden of these diseases related to epidemiology, clinical features, diagnosis ...
Abhay Kumar, Singh   +3 more
openaire   +2 more sources

Neuromuscular Blocking Agents

2016
Many drugs used for induction or maintenance of anaesthesia provide a degree of skeletal muscle relaxation, but in general this is only mild to moderate at a surgical plane of anaesthesia. This chapter looks at different ways to achieve more profound muscle relaxation, neuromuscular blocking agents (NMBAs) and their mechanism, monitoring the ...
Renu Agarwal, Priya Mathur
openaire   +2 more sources

Neuromuscular blocking agents

Reactions Weekly, 2012
The effect of different antiepileptic drugs on the pharmacokinetics of various neuromuscular blocking agents including atracurium, cisatracurium, doxacurium, mivacurium, pancuronium, pipecuronium, rapacuronium, rocuronium and vecuronium are described. Also, potential pharmacodynamic interactions are highlighted.
openaire   +2 more sources

Neuromuscular Blocking Agents

1990
In animal experiments succinylcholine increases ICP (Cottrell et al. 1983, Lanier et al. 1986). The increase in ICP is also observed after pre-treatment with thiopentone (Thiagarajah et al. 1988). In dogs subjected to succinylcholine injection, CBF increases within a few minutes and this hyperperfusion is accompanied by EEG activation (Mori et al. 1973,
Jörn Bo Madsen, Georg Emil Cold
openaire   +1 more source

Neuromuscular Blocking Agents

Journal of Pharmacy Practice, 1994
Neuromuscular blocking (NMB) agents are frequently used in the operating room (OR) as well as the intensive care units. The number of NMB agents available for use in these areas continues to increase. The clinician currently has 10 agents from which to choose, with another (rocuronium) soon to be available.
openaire   +1 more source

Dosing of neuromuscular blocking agents in patients with obesity: A narrative review

Anaesthesia and Intensive Care, 2021
, Jeffrey F Barletta
exaly  

Myotonia and Neuromuscular Blocking Agents

Anesthesiology, 1978
M M, Mitchell, H H, Ali, J J, Savarese
openaire   +2 more sources

Home - About - Disclaimer - Privacy